Mistletoe Extracts Inhibit Progressive Growth of Prostate Cancer Cells
Cells · 2025
DOI: 10.3390/cells14191535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Sascha D Markowitsch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: Plant Extracts, Prostatic Neoplasms, Mistletoe. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: WALA Heilmittel GmbH, Bad Boll, Germany, König-Baudouin-Stiftung & Familie Harald G. Müller Fonds, Brussels, Belgium, Dr. Peter und Gabriele Strohmaier-Stiftung, Gütersloh, Germany.
Abstract (Originalsprache)
Although multimodal therapeutic management has significantly improved outcome in prostate cancer (PCa) patients, treatment options for castrate-resistant disease remain challenging. Plant-derived mistletoe extracts have supported cancer patients and are, therefore, widely used as complementary medicine. However, mechanisms behind possible mistletoe benefits to PCa patients remain to be explored. The present study was designed to evaluate the effect of mistletoe extracts from four different host trees (Tiliae, Populi, Salicis, and Crataegi) on the growth and proliferation of PCa cell lines in vitro. PC3, DU145, and LNCaP cells were used to evaluate tumor cell growth (MTT assay) and proliferation (BrdU incorporation assay). Clonogenicity, apoptosis, cell cycle, and cell-cycle-regulating proteins (cyclin-dependent kinases (CDKs) and cyclins) were investigated, as was CD44 standard and splice variant expression and integrin α and β receptors. SiRNA knockdown studies were employed to investigate the functional relevance of integrins. All mistletoe extracts significantly inhibited cell growth in a dose-dependent manner and cell proliferation and clonogenicity were suppressed. Populi and Salicis induced cell-cycle arrest in the G2/M phase and increased apoptosis. Both extracts down-regulated CDK1 and cyclin A and altered CD44 expression. Integrins α5 in all cell lines and α6 in DU145 and LNCaP were particularly diminished. Knocking down α5 and α6 induced cell growth inhibition in DU145. Mistletoe extracts block the growth and proliferation of PCa cells in vitro and therefore qualify for use in future animal studies to evaluate mistletoe as an adjunct to standard PCa treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.
- Department of Urology, Goethe-University, 60590 Frankfurt am Main, Germany.
ORCID-Profile: Eva Juengel, Roman A Blaheta
Förderung
- WALA Heilmittel GmbH, Bad Boll, Germany
- König-Baudouin-Stiftung & Familie Harald G. Müller Fonds, Brussels, Belgium
- Dr. Peter und Gabriele Strohmaier-Stiftung, Gütersloh, Germany
- Brigitta & Norbert Muth Stiftung, Wiesbaden, Germany
Zitieren
APA
Markowitsch, S. D., Albrecht, L., Meiborg, M., Rutz, J., Thomas, A., Chun, F. K., Haferkamp, A., Juengel, E., & Blaheta, R. A. (2025). Mistletoe Extracts Inhibit Progressive Growth of Prostate Cancer Cells. Cells. https://doi.org/10.3390/cells14191535
Vancouver
Markowitsch SD, Albrecht L, Meiborg M, Rutz J, Thomas A, Chun FK, et al. Mistletoe Extracts Inhibit Progressive Growth of Prostate Cancer Cells. Cells. 2025. doi:10.3390/cells14191535
BibTeX
@article{Markowitsch2025,
author = {Markowitsch, Sascha D and Albrecht, Larissa and Meiborg, Moritz and Rutz, Jochen and Thomas, Anita and Chun, Felix K-H and Haferkamp, Axel and Juengel, Eva and Blaheta, Roman A},
title = {Mistletoe Extracts Inhibit Progressive Growth of Prostate Cancer Cells},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14191535}
}
EUVIMED